Recent Finacing
Recent Raise
Ultragenyx develops therapeutics for rare and ultra-rare disorders, advancing clinical-stage programs (including UX-001 for HIBM), creating new candidates, and pursuing partnerships with specialized development teams.
Focus Areas
Recent Investors
Total Raised
Funding round
Investors
See the team members at Ultragenyx Pharmaceutical.
